Literature DB >> 3863616

Specificity of activated human protein C.

S R Stone, J Hofsteenge.   

Abstract

Peptide p-nitroanilide substrates and peptidylchloromethane inhibitors were used to examine the specificity of activated human Protein C. Substrates with arginine in the P1 position had the highest activity. The best substrates and inhibitors, as judged by the second-order rate constant for their interaction with the enzyme, had an apolar residue in the P2 position. In contrast with thrombin [Kettner & Shaw (1981) Methods Enzymol. 80, 826-842], activated Protein C was able to accommodate large hydrophobic residues such as phenylalanine and leucine in the P2 position. In the P3 position, the enzyme preferred an apolar D-amino acid residue. The results of the present study have also indicated a suitable substrate and inhibitor to be used in the assay of functional protein C and of thrombomodulin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3863616      PMCID: PMC1152642          DOI: 10.1042/bj2300497

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

1.  A simple test for inactivation of an enzyme during assay.

Authors:  M J Selwyn
Journal:  Biochim Biophys Acta       Date:  1965-07-29

Review 2.  Protein-C: biochemistry, physiology, and clinical implications.

Authors:  C T Esmon
Journal:  Blood       Date:  1983-12       Impact factor: 22.113

3.  Active-site mapping of bovine and human blood coagulation serine proteases using synthetic peptide 4-nitroanilide and thio ester substrates.

Authors:  K Cho; T Tanaka; R R Cook; W Kisiel; K Fujikawa; K Kurachi; J C Powers
Journal:  Biochemistry       Date:  1984-02-14       Impact factor: 3.162

4.  The irreversible inhibition of urokinase, kidney-cell plasminogen activator, plasmin and beta-trypsin by 1-(N-6-amino-n-hexyl)carbamoylimidazole.

Authors:  B Walker; D T Elmore
Journal:  Biochem J       Date:  1984-07-01       Impact factor: 3.857

5.  Inhibition of trypsin-like serine proteinases by tripeptide arginyl and lysyl chloromethylketones.

Authors:  H R Lijnen; M Uytterhoeven; D Collen
Journal:  Thromb Res       Date:  1984-06-01       Impact factor: 3.944

6.  Isolation and characterization of thrombomodulin from human placenta.

Authors:  H H Salem; I Maruyama; H Ishii; P W Majerus
Journal:  J Biol Chem       Date:  1984-10-10       Impact factor: 5.157

7.  A functional assay of protein C in human plasma.

Authors:  N Sala; W G Owen; D Collen
Journal:  Blood       Date:  1984-03       Impact factor: 22.113

8.  The action of thrombin on peptide p-nitroanilide substrates. Substrate selectivity and examination of hydrolysis under different reaction conditions.

Authors:  R Lottenberg; J A Hall; M Blinder; E P Binder; C M Jackson
Journal:  Biochim Biophys Acta       Date:  1983-02-15

9.  Solution composition dependent variation in extinction coefficients for p-nitroaniline.

Authors:  R Lottenberg; C M Jackson
Journal:  Biochim Biophys Acta       Date:  1983-02-15

10.  Determination of functional levels of protein C, an antithrombotic protein, using thrombin-thrombomodulin complex.

Authors:  P C Comp; R R Nixon; C T Esmon
Journal:  Blood       Date:  1984-01       Impact factor: 22.113

View more
  16 in total

1.  Kinetic differentiation between enzyme inactivation involving complex-formation with the inactivator and that involving a conformation-change step.

Authors:  C Liu; C L Tsou
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

2.  Implication of protein S thrombin-sensitive region with membrane binding via conformational changes in the gamma-carboxyglutamic acid-rich domain.

Authors:  D Borgel; P Gaussem; C Garbay; C Bachelot-Loza; T Kaabache; W Q Liu; B Brohard-Bohn; B Le Bonniec; M Aiach; S Gandrille
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

3.  Simultaneous analysis of enzyme structure and activity by kinetic capillary electrophoresis-MS.

Authors:  Gleb G Mironov; Christopher M Clouthier; Abdullah Akbar; Jeffrey W Keillor; Maxim V Berezovski
Journal:  Nat Chem Biol       Date:  2016-09-05       Impact factor: 15.040

4.  A catalytically active high-Mr form of human cathepsin B from sputum.

Authors:  D J Buttle; B C Bonner; D Burnett; A J Barrett
Journal:  Biochem J       Date:  1988-09-15       Impact factor: 3.857

5.  Interaction of activated protein C with serpins.

Authors:  J M Hermans; S R Stone
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

6.  Synthesis and properties of Cbz-Phe-Arg-CHN2 (benzyloxycarbonylphenylalanylarginyldiazomethane) as a proteinase inhibitor.

Authors:  A Zumbrunn; S Stone; E Shaw
Journal:  Biochem J       Date:  1988-03-01       Impact factor: 3.857

7.  Effect of thrombomodulin on the kinetics of the interaction of thrombin with substrates and inhibitors.

Authors:  J Hofsteenge; H Taguchi; S R Stone
Journal:  Biochem J       Date:  1986-07-01       Impact factor: 3.857

8.  Structure-Activity Relationships of Potent, Targeted Covalent Inhibitors That Abolish Both the Transamidation and GTP Binding Activities of Human Tissue Transglutaminase.

Authors:  Abdullah Akbar; Nicole M R McNeil; Marie R Albert; Viviane Ta; Gautam Adhikary; Karine Bourgeois; Richard L Eckert; Jeffrey W Keillor
Journal:  J Med Chem       Date:  2017-09-14       Impact factor: 7.446

9.  The synthesis and properties of peptidylmethylsulphonium salts with two cationic residues as potential inhibitors of prohormone processing.

Authors:  A Zumbrunn; S Stone; E Shaw
Journal:  Biochem J       Date:  1988-12-15       Impact factor: 3.857

10.  Synthesis and properties of peptidyl derivatives of arginylfluoromethanes.

Authors:  H Angliker; P Wikström; P Rauber; S Stone; E Shaw
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.